Annual D&A
$119.00 K
-$50.00 K-29.59%
December 1, 2023
Summary
- As of February 20, 2025, RNTX annual depreciation & amortization is $119.00 thousand, with the most recent change of -$50.00 thousand (-29.59%) on December 1, 2023.
- During the last 3 years, RNTX annual D&A has fallen by -$44.00 thousand (-26.99%).
Performance
RNTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$0.00
-$4000.00-100.00%
September 1, 2024
Summary
- As of February 20, 2025, RNTX quarterly depreciation & amortization is $0.00, with the most recent change of -$4000.00 (-100.00%) on September 1, 2024.
- Over the past year, RNTX quarterly D&A has dropped by -$59.00 thousand (-100.00%).
Performance
RNTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$115.00 K
-$12.00 K-9.45%
September 1, 2024
Summary
- As of February 20, 2025, RNTX TTM depreciation & amortization is $115.00 thousand, with the most recent change of -$12.00 thousand (-9.45%) on September 1, 2024.
- Over the past year, RNTX TTM D&A has dropped by -$20.00 thousand (-14.81%).
Performance
RNTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
RNTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.6% | -100.0% | -14.8% |
| 3 y3 years | -27.0% | -100.0% | -32.8% |
| 5 y5 years | -45.4% | -100.0% | -40.7% |
RNTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -100.0% | at low | -32.7% | -4.3% |
| 5 y | 5-year | -29.6% | at low | -100.0% | at low | -51.3% | -42.6% |
| alltime | all time | -63.4% | at low | -100.0% | at low | -51.3% | -42.6% |
Rein Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $115.00 K(-9.4%) |
| Jun 2024 | - | $4000.00(-93.2%) | $127.00 K(-5.9%) |
| Mar 2024 | - | $59.00 K(+13.5%) | $135.00 K(+13.4%) |
| Dec 2023 | $119.00 K(-29.6%) | $52.00 K(+333.3%) | $119.00 K(+8.2%) |
| Sep 2023 | - | $12.00 K(0.0%) | $110.00 K(-22.0%) |
| Jun 2023 | - | $12.00 K(-72.1%) | $141.00 K(-17.5%) |
| Mar 2023 | - | $43.00 K(0.0%) | $171.00 K(+1.2%) |
| Dec 2022 | $169.00 K(+39.7%) | $43.00 K(0.0%) | $169.00 K(+1.8%) |
| Sep 2022 | - | $43.00 K(+2.4%) | $166.00 K(+2.5%) |
| Jun 2022 | - | $42.00 K(+2.4%) | $162.00 K(+1.3%) |
| Mar 2022 | - | $41.00 K(+2.5%) | $160.00 K(+32.2%) |
| Dec 2021 | $121.00 K(-25.8%) | $40.00 K(+2.6%) | $121.00 K(+33.0%) |
| Sep 2021 | - | $39.00 K(-2.5%) | $91.00 K(+37.9%) |
| Jun 2021 | - | $40.00 K(+1900.0%) | $66.00 K(-30.5%) |
| Mar 2021 | - | $2000.00(-80.0%) | $95.00 K(-41.7%) |
| Dec 2020 | $163.00 K | $10.00 K(-28.6%) | $163.00 K(-28.5%) |
| Sep 2020 | - | $14.00 K(-79.7%) | $228.00 K(-3.4%) |
| Jun 2020 | - | $69.00 K(-1.4%) | $236.00 K(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $70.00 K(-6.7%) | $194.00 K(+25.2%) |
| Dec 2019 | $155.00 K(-28.9%) | $75.00 K(+240.9%) | $155.00 K(+20.2%) |
| Sep 2019 | - | $22.00 K(-18.5%) | $129.00 K(-33.5%) |
| Jun 2019 | - | $27.00 K(-12.9%) | $194.00 K(-4.4%) |
| Mar 2019 | - | $31.00 K(-36.7%) | $203.00 K(-6.9%) |
| Dec 2018 | $218.00 K(+69.0%) | $49.00 K(-43.7%) | $218.00 K(+2.3%) |
| Sep 2018 | - | $87.00 K(+141.7%) | $213.00 K(+28.3%) |
| Jun 2018 | - | $36.00 K(-21.7%) | $166.00 K(+8.5%) |
| Mar 2018 | - | $46.00 K(+4.5%) | $153.00 K(+18.6%) |
| Dec 2017 | $129.00 K(-44.4%) | $44.00 K(+10.0%) | $129.00 K(+1.6%) |
| Sep 2017 | - | $40.00 K(+73.9%) | $127.00 K(-12.4%) |
| Jun 2017 | - | $23.00 K(+4.5%) | $145.00 K(-22.5%) |
| Mar 2017 | - | $22.00 K(-47.6%) | $187.00 K(-19.4%) |
| Dec 2016 | $232.00 K(-28.6%) | $42.00 K(-27.6%) | $232.00 K(+22.1%) |
| Sep 2016 | - | $58.00 K(-10.8%) | $190.00 K(+43.9%) |
| Jun 2016 | - | $65.00 K(-3.0%) | $132.00 K(+97.0%) |
| Mar 2016 | - | $67.00 K | $67.00 K |
| Dec 2015 | $325.00 K | - | - |
FAQ
- What is Rein Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Rein Therapeutics?
- What is Rein Therapeutics annual D&A year-on-year change?
- What is Rein Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rein Therapeutics?
- What is Rein Therapeutics quarterly D&A year-on-year change?
- What is Rein Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Rein Therapeutics?
- What is Rein Therapeutics TTM D&A year-on-year change?
What is Rein Therapeutics annual depreciation & amortization?
The current annual D&A of RNTX is $119.00 K
What is the all time high annual D&A for Rein Therapeutics?
Rein Therapeutics all-time high annual depreciation & amortization is $325.00 K
What is Rein Therapeutics annual D&A year-on-year change?
Over the past year, RNTX annual depreciation & amortization has changed by -$50.00 K (-29.59%)
What is Rein Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of RNTX is $0.00
What is the all time high quarterly D&A for Rein Therapeutics?
Rein Therapeutics all-time high quarterly depreciation & amortization is $87.00 K
What is Rein Therapeutics quarterly D&A year-on-year change?
Over the past year, RNTX quarterly depreciation & amortization has changed by -$59.00 K (-100.00%)
What is Rein Therapeutics TTM depreciation & amortization?
The current TTM D&A of RNTX is $115.00 K
What is the all time high TTM D&A for Rein Therapeutics?
Rein Therapeutics all-time high TTM depreciation & amortization is $236.00 K
What is Rein Therapeutics TTM D&A year-on-year change?
Over the past year, RNTX TTM depreciation & amortization has changed by -$20.00 K (-14.81%)